Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family

被引:18
|
作者
Wang, Xiao-Fei
Cohen, William M.
Castelli, Florence A.
Almunia, Christine
Lethe, Bernard
Pouvelle-Moratille, Sandra
Munier, Gaetan
Charron, Dominique
Menez, Andre
Zarour, Hassan M.
van der Bruggen, Pierre
Busson, Marc
Maillere, Bernard [1 ]
机构
[1] CEA Saclay, Prot Engn & Res Dept, F-91191 Gif Sur Yvette, France
[2] Catholic Univ Louvain, Ludwig Inst Canc Res & Cellular Genet Unit, B-1200 Brussels, Belgium
[3] Hop St Louis, INSERM U662, F-75475 Paris 10, France
[4] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA
[5] Univ Pittsburgh, Sch Med, Div Hematol Oncol, Dept Immunol, Pittsburgh, PA 15213 USA
关键词
HLA-DP4; antigens/peptides/epitopes; CD4+T lymphocyte; tumor; MAGE;
D O I
10.1007/s00262-006-0230-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Because of the high frequency of HLA-DP4 in the Caucasian population, we have selectively delineated HLA-DP4 restricted T cell epitopes in the MAGE-A tumor antigens. We identified 12 good binders to HLA-DP4 and investigated the capacity of the seven best binders to induce in vitro specific CD4+ T cell lines from HLA-DP4 healthy donors. We found that the MAGE-A1 90-104 peptide exhibited a high and constant frequency of CD4+ T cell precursors in all the six tested donors. The MAGE-A1 268-282 peptide was found immunogenic in only two donors but with a high precursor frequency. The MAGE-A12 127-141 peptide was T cell stimulating in six different donors and induced fewer T cell lines. The peptide-specific T cell lines were stimulated by DC loaded with the lysates of cells transfected with MAGE-A1 or MAGE-A12, or loaded with the recombinant protein. We also show that the immunoreactivity of CD4+ T cell epitopes restricted to the same HLA II molecule may vary from one individual to another, as a result of inter-individual variations in the CD4+ T cell repertoire.
引用
收藏
页码:807 / 818
页数:12
相关论文
共 50 条
  • [1] Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family
    Xiao-Fei Wang
    William M. Cohen
    Florence A. Castelli
    Christine Almunia
    Bernard Lethé
    Sandra Pouvelle-Moratille
    Gaetan Munier
    Dominique Charron
    André Ménez
    Hassan M. Zarour
    Pierre van der Bruggen
    Marc Busson
    Bernard Maillère
    [J]. Cancer Immunology, Immunotherapy, 2007, 56 : 807 - 818
  • [2] Prediction of CD4+ T cell epitopes restricted to HLA-DP4 molecules
    Busson, Marc
    Castelli, Florence A.
    Wang, Xiao-Fei
    Cohen, William M.
    Charron, Dominique
    Menez, Andre
    Maillere, B.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2006, 317 (1-2) : 144 - 151
  • [3] TCR Gene Transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 Epitopes as Melanoma-Specific Immune Targets
    Straetemans, Trudy
    van Brakel, Mandy
    van Steenbergen, Sabine
    Broertjes, Marieke
    Drexhage, Joost
    Hegmans, Joost
    Lambrecht, Bart N.
    Lamers, Cor
    van der Bruggen, Pierre
    Coulie, Pierre G.
    Debets, Reno
    [J]. CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2012,
  • [4] Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule
    Cohen, William M.
    Pouvelle-Moratille, Sandra
    Wang, Xiao-Fei
    Farci, Sandrine
    Munier, Gaetan
    Charron, Dominique
    Menez, Andre
    Busson, Marc
    Maillere, Bernard
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (09): : 5401 - 5408
  • [5] A MAGE-A3 peptide presented by HLA-DP4 tumor cells to CD4+ cytolytic T lymphocytes
    Schultz, ES
    Lethé, B
    Van Snick, J
    Chaux, P
    Thielemans, K
    Corthals, J
    Heirman, C
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 563 - 563
  • [6] A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes
    Schultz, ES
    Lethé, B
    Cambiaso, CL
    Van Snick, J
    Chaux, P
    Corthals, J
    Heirman, C
    Thielemans, K
    Boon, T
    van der Bruggen, P
    [J]. CANCER RESEARCH, 2000, 60 (22) : 6272 - 6275
  • [7] A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes.
    Schultz, ES
    Schuler-Thurner, B
    Lethé, B
    Cambiaso, CL
    Van Snick, J
    Chaux, P
    Corthals, J
    Heirman, C
    Thielemans, K
    Boon, T
    van der Bruggen, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (06) : 1170 - 1170
  • [8] Identification of a promiscuous T-cell epitope encoded by multiple members of the MAGE family
    Tanzarella, S
    Russo, V
    Lionello, I
    Dalerba, P
    Rigatti, D
    Bordignon, C
    Traversari, C
    [J]. CANCER RESEARCH, 1999, 59 (11) : 2668 - 2674
  • [9] A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells
    Zhang, Y
    Renkvist, N
    Sun, ZJ
    Schuler-Thurner, B
    Glaichenhaus, N
    Schuler, G
    Boon, T
    van der Bruggen, P
    Colau, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1066 - 1075
  • [10] Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product
    Visseren, MJW
    vanderBurg, SH
    vanderVoort, EIH
    Brandt, RMP
    Schrier, PI
    vanderBruggen, P
    Boon, T
    Melief, CJM
    Kast, WM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (01) : 125 - 130